Metagenomi CEO auto-sells 2,140 shares for tax
Metagenomi Therapeutics CEO Jian Irish reported an automatic sale of shares to cover tax withholding from vested RSUs.
Rhea-AI Filing Summary
Metagenomi Therapeutics, Inc. (MGX) reported that President and Chief Executive Officer and director Jian Irish sold 2,140 shares of common stock on September 8, 2026 at $1.1584 per share. After this sale, she held 375,393 shares of common stock directly.
According to the filing, these shares were automatically sold to satisfy tax withholding obligations arising from the vesting of restricted stock units granted on April 1, 2024 and April 1, 2025, and the transaction "does not represent a volitional trade" by Jian Irish. The filing also notes additional indirect holdings of common stock in two 2023 irrevocable trusts, for which she disclaims beneficial ownership except to the extent of her pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 2,140 shares
Net Sell
3 txns
Insider
Irish Jian
Role
See Remarks
Sold
2,140 shs ($2K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1 | 2,140 | $1.1584 | $2K |
| holding | Common Stock F2 | -- | -- | -- |
| holding | Common stock F3 | -- | -- | -- |
Holdings After Transaction:
Common Stock — 375,393 shares (Direct);
Common Stock — 585,427 shares (Indirect, By Trust)
Footnotes (3)
- F1. These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on April 1, 2024 and April 1, 2025, and does not represent a volitional trade by the Reporting Person.
- F2. Shares held by the Bruce Irish 2023 Irrevocable Trust FBO Jian Irish. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F3. Shares held by the Jian Irish 2023 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Key Figures
Shares sold: 2,140 shares
Sale price per share: $1.1584 per share
Direct holdings after transaction: 375,393 shares
+1 more
4 metrics
Shares sold
2,140 shares
Automatic sale of common stock on September 8, 2026
Sale price per share
$1.1584 per share
Price for the 2,140 shares sold on September 8, 2026
Direct holdings after transaction
375,393 shares
Common stock held directly by Jian Irish after the sale
Net shares sold
2,140 shares
Net buy/sell activity across all reported transactions in this Form 4
Key Terms
restricted stock units, tax withholding obligations, pecuniary interest, irrevocable trust
4 terms
restricted stock units financial
"upon the vesting of certain restricted stock units granted"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"sold for the purpose of satisfying the Reporting Person's tax withholding obligations"
pecuniary interest financial
"except to the extent of her pecuniary interest therein"
irrevocable trust financial
"Bruce Irish 2023 Irrevocable Trust FBO Jian Irish"
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.
FAQ
What insider transaction did MGX report for Jian Irish on September 8, 2026?
Metagenomi Therapeutics reported that Jian Irish sold 2,140 shares of common stock on September 8, 2026 at $1.1584 per share, in a transaction described as a sale in the open market or a private transaction.
Were the MGX insider transactions by Jian Irish under a Rule 10b5-1 trading plan?
No. The document-level Rule 10b5-1 checkbox is marked not affirming a trading plan, and the footnotes describe the sale as an automatic tax withholding transaction rather than a pre-arranged 10b5-1 plan trade.
Does Jian Irish have indirect holdings of MGX through trusts?
Yes. The Form 4 reports indirect ownership of common stock held by the Bruce Irish 2023 Irrevocable Trust FBO Jian Irish and the Jian Irish 2023 Irrevocable Trust. Jian Irish disclaims beneficial ownership except to the extent of her pecuniary interest.
What is the net effect of this Form 4 transaction on Jian Irish’s MGX ownership?
The net effect is a disposition of 2,140 shares of common stock, leaving 375,393 shares held directly. Additional indirect holdings exist through two irrevocable trusts, with beneficial ownership disclaimed except for any pecuniary interest.
AI-generated analysis. How Rhea-AI works. Not financial advice.
